MGMikhail Grin

Mikhail Grin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikhail Grin has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • A. B. Trusova

    Samara National Research University

    1 shared publication
  • Alexey Valeryevich Feofanov

    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia

    1 shared publication
  • Anastasia Ignatova

    The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

    1 shared publication
  • Andrey A. Pankratov

    Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 86 Vernadsky Avenue, 119571 Moscow, Russia

    1 shared publication
  • Anna Plutinskaya

    P. Hertsen Moscow Oncology Research Institute—Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 2nd Botkinsky pr. 3, 125284 Moscow, Russia

    1 shared publication
  • Daria Vedenyapina

    Department of Chemistry and Technology of Biologically Active Compounds, Medical and Organic Chemistry, Lomonosov Institute of Fine Chemical Technologies MIREA-Russian Technological University (RTU MIREA), 119571 Moscow, Russia

    1 shared publication

Latest Publications

  • Open Access

    Method for Isolating Hypericin from Hypericum perforatum and Preparing Its Micelles for Biomedical Applications

    by Dmitry Medvedev, Vasilisa Dalinina, Polina Golik, Polina Lavrinova, Ekaterina Plotnikova, Maksim Usachev, Veronika Usatova, Mikhail Grin, Tatiana Abakumova, Petr Ostroverkhov

    Hypericin (Hyp) is a naturally occurring photosensitizer (PS) exhibiting a broad spectrum of biological activities. However, its high hydrophobicity significantly limits its medical applicability. This study aimed to develop an efficient method for extracting Hyp from Hypericum perforatum L. biomass and to obtain its water-soluble micellar formulation. A protocol for Hyp isolation from the aerial parts of the plant was established, involving a preliminary defatting step using a Soxhlet apparatus, followed by ultrasonic-assisted extraction with acetone. The water-soluble formulation was prepared via the thin-film hydration method using the nonionic block copolymer Pluronic F-127. The resulting micelles demonstrated colloidal stability, with a mean hydrodynamic diameter of approximately 30 nm. A high Hyp loading efficiency was achieved, with an encapsulation efficiency (EE) of 95.4 ± 2.7%, yielding a concentration of 600.6 ± 16.6 µM within the micellar formulation. In vitro biological studies were performed using the murine GL261 glioblastoma cell line. The micellar Hyp formulation exhibited efficient time-dependent cellular accumulation and photoinduced cytotoxicity, with no observable dark toxicity. The proposed method enables the production of a stable Hyp formulation that retains its photosensitizing properties, thereby opening promising avenues for its application in photodynamic and sonodynamic therapies.

  • Open Access

    Collagen-Based Delivery Systems for the Prevention of Alveolitis: A Narrative Review and Rationale for Biopharmaceutical Development Requirements

    by Hadi Darawsheh, Marina M. Shumkova, Liliya M. Buraya, Maria V. Pomytkina, Ghazaleh Pouya, Farida Bakieva, Mikhail Grin, Elena O. Bakhrushina, Natalia Kireeva, Sergey Dydykin, et al.

    Alveolitis remains a common postoperative complication following tooth extraction, characterized by inflammation and delayed socket healing. Collagen-based materials have shown promise in promoting tissue regeneration and reducing inflammation. This review evaluates the efficacy of collagen in the prevention of alveolitis, with a focus on the development and application of topical delivery systems such as gels and collagen sponges. Special attention is given to the local application of these systems within the extraction socket and their performance under oral conditions. The study analyzes current evidence on the pathogenesis of alveolitis, the biological properties of collagen relevant to wound healing, and pharmaceutical strategies for enhancing its clinical effectiveness. The findings support the feasibility of using biodegradable, site-specific collagen-based formulations for alveolitis prevention. Such systems may provide a prolonged therapeutic effect, stabilize blood clots, reduce microbial contamination, and support angiogenesis and osteogenesis throughout the healing process. This approach offers a promising direction for improving post-extraction management protocols in dental surgery.

  • Open Access

    A New Glutathione-Cleavable Theranostic for Photodynamic Therapy Based on Bacteriochlorin e and Styrylnaphthalimide Derivatives

    by Marina A. Pavlova, Pavel A. Panchenko, Ekaterina A. Alekhina, Anastasia A. Ignatova, Anna D. Plyutinskaya, Andrey A. Pankratov, Dmitriy A. Pritmov, Mikhail A. Grin, Alexey V. Feofanov, Olga A. Fedorova

    Herein, we report a new conjugate BChl–S–S–NI based on the second-generation photosensitizer bacteriochlorin e6 (BChl) and a 4-styrylnaphthalimide fluorophore (NI), which is cleaved into individual functional fragments in the intracellular medium. The chromophores in the conjugate were cross-linked by click chemistry via a bis(azidoethyl)disulfide bridge which is reductively cleaved by the intracellular enzyme glutathione (GSH). A photophysical investigation of the conjugate in solution by using optical spectroscopy revealed that the energy transfer process is realized with high efficiency in the conjugated system, leading to the quenching of the emission of the fluorophore fragment. It was shown that the conjugate is cleaved by GSH in solution, which eliminates the possibility of energy transfer and restores the fluorescence of 4-styrylnaphthalimide. The photoinduced activity of the conjugate and its imaging properties were investigated on the mouse soft tissue sarcoma cell line S37. Phototoxicity studies in vitro show that the BChl–S–S–NI conjugate has insignificant dark cytotoxicity in the concentration range from 15 to 20,000 nM. At the same time, upon photoexcitation, it exhibits high photoinduced activity.


  • Open Access

    Liposomal Form of 2,4-Dinitrophenol Lipophilic Derivatives as a Promising Therapeutic Agent for ATP Synthesis Inhibition

    by Kseniya Yu. Vlasova, Petr Ostroverkhov, Daria Vedenyapina, Tamara Yakimova, Alla Trusova, Galina Yurievna Lomakina, Stepan Sergeevich Vodopyanov, Mikhail Grin, Natalia Klyachko, Vladimir Chekhonin, et al.

    Mitochondrial uncoupler 2,4-dinitrophenol (2,4-DNP) is a promising antidiabetic and antiobesity agent. Its clinical use is limited by a narrow dynamic range and accumulation in non-target sensitive organs, which results in whole-body toxicity. A liposomal formulation could enable the mentioned drawbacks to be overcome and simplify the liver-targeted delivery and sustained release of 2,4-DNP. We synthesized 2,4-DNP esters with carboxylic acids of various lipophilic degrees using carboxylic acid chloride and then loaded them into liposomes. We demonstrated the effective increase in the entrapment of 2,4-DNP into liposomes when esters were used. Here, we examined the dependence of the sustained release of 2,4-DNP from liposomes on the lipid composition and LogPoct of the ester. We posit that the optimal chain length of the ester should be close to the palmitic acid and the lipid membrane should be composed of phospholipids with a certain phase transition point depending on the desired release rate. The increased effect of the ATP synthesis inhibition of the liposomal forms of caproic and palmitic acid esters compared to free molecules in liver hepatocytes was demonstrated. The liposomes’ stability could well be responsible for this result. This work demonstrates promising possibilities for the liver-targeted delivery of the 2,4-DNP esters with carboxylic acids loaded into liposomes for ATP synthesis inhibition.